Results of Coronary Artery Bypass Grafting in Obese Patients
Launched by TOMSK NATIONAL RESEARCH MEDICAL CENTER OF THE RUSSIAN ACADEMY OF SCIENCES · Jun 1, 2021
Trial Information
Current as of June 05, 2025
Completed
Keywords
ClinConnect Summary
This study is planned to assess the effect of obesity (BMI over 30 kg / m2) on hospital outcomes of isolated coronary artery bypass grafting in patients with chronic ischemic heart disease.
It is planned to retrospectively enroll around 500 patients who underwent coronary artery bypass grafting for chronic ischemic heart disease at the Tomsk Research Institute of Cardiology. It is planned to develop a register of isolated coronary bypass grafting procedures, to conduct a comparative analysis of hospital results in obese patients (BMI more than 30 kg / m2) and without (BMI less than 30 kg /...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Clinical diagnosis of chronic ischemic heart disease
- • Indications for cardiac surgery
- • Stenosis of more than 75% of the trunk of the left coronary artery, or proximal stenosis of the anterior descending artery and/or stenosis of more than 75% of two or more coronary arteries
- Exclusion Criteria:
- • The presence of organic heart defects of rheumatic and infectious etiology;
- • Acute myocardial infarction;
- • Less than 3 months after acute coronary or cerebrovascular events;
- • Severe pulmonary hypertension not associated with mitral regurgitation (above 75 mmHg);
- • Contraindications for operations with cardiopulmonary bypass;
- • Severe course of bronchial asthma,
- • Chronic obstructive pulmonary disease in the acute stage;
- • Refusal of the patient or relatives to participate in the study.
About Tomsk National Research Medical Center Of The Russian Academy Of Sciences
The Tomsk National Research Medical Center of the Russian Academy of Sciences is a leading clinical research institution dedicated to advancing medical science and healthcare innovation. Committed to high standards of clinical excellence, the center integrates cutting-edge research with patient care, focusing on a diverse range of medical disciplines. With a robust infrastructure and a multidisciplinary team of experts, the center actively sponsors and conducts clinical trials aimed at improving diagnostic, therapeutic, and preventive strategies, ultimately contributing to the global body of medical knowledge and enhancing patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tomsk, Tomsk State, Russian Federation
Patients applied
Trial Officials
Andrey S Pryakhin, PhD
Principal Investigator
Tomsk NRMC
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials